Evidence map›Paper›PMID 33202828›Full record

ArticleMetabolites2020

Potent Antifungal Properties of Dimeric Acylphloroglucinols from

Noemi Tocci, Tobias Weil, Daniele Perenzoni, Marco Moretto, Nicolai Nürk, Santiago Madriñán, Ruggero Ferrazza, Graziano Guella, Fulvio Mattivi

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Noemi TocciResearch and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all'Adige (TN), Italy.
Tobias WeilResearch and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all'Adige (TN), Italy.
Daniele PerenzoniResearch and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all'Adige (TN), Italy.
Marco MorettoResearch and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all'Adige (TN), Italy.ORCID 0000-0003-4555-7243
Nicolai NürkDepartment of Plant Systematics, BayCEER, University of Bayreuth, 95447 Bayreuth, Germany.ORCID 0000-0002-0471-644X
Santiago MadriñánDepartamento de Ciencias Biológicas, Universidad de los Andes, Bogotá 111711, Colombia.
Ruggero FerrazzaDepartment of Physics, University of Trento, 38123 Trento, Italy.
Graziano GuellaDepartment of Physics, University of Trento, 38123 Trento, Italy.ORCID 0000-0002-1799-0819
Fulvio MattiviResearch and Innovation Centre, Fondazione Edmund Mach, 38010 San Michele all'Adige (TN), Italy.
Fondazione Edmund Mach · ITUniversity of Trento · ITUniversidad de Los Andes · COUniversity of Bayreuth · DE

Funding

Provincia Autonoma di Trento Fondazione Edmund Mach, ADP 2016
6 · The paper itself

Abstract

The success of antifungal therapies is often hindered by the limited number of available drugs. To close the gap in the antifungal pipeline, the search of novel leads is of primary importance, and here the exploration of neglected plants has great promise for the discovery of new principles. Through bioassay-guided isolation, uliginosin B and five new dimeric acylphloroglucinols (uliginosins C-D, and 3'prenyl uliginosins B-D), besides cembrenoids, have been isolated from the lipophilic extract of

Indexed as

acylphloroglucinolsantifungal activitybioactive compoundscytotoxicityHypericummass spectrometrymechanism of actionnuclear magnetic resonance spectroscopystructural annotation

Identifiers

PMID33202828
PMCPMC7697946
OpenAlexW3106170399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.